Abstract
Increasing evidence indicates that the nm23 genes, initially documented as suppressors of metastasis progression, are involved in normal development and differentiation. We have shown previously that the murine nm23 gene enhances pheochromocytoma PC12 cells responsiveness to NGF by accelerating cell growth arrest and neurite outgrowth. The present study was aimed at elucidating the mechanisms by which nm23 controls cell proliferation and promotes neuronal differentiation. We demonstrated that nm23 modulates the expression of the Rb2/p130 gene, a negative regulator of cell cycle progression also implicated in the maintenance of the differentiated state. Furthermore, we showed that nm23-H1 mutants, defective in inhibiting the invasive phenotype, downregulate Rb2/p130 expression and inhibit NGF-induced PC12 cell differentiation. In synthesis, our results provide first evidence of interplay between the nm23 and the Rb2/p130 genes in driving PC12 cells neuronal differentiation and suggest that the antimetastatic and the differentiative nm23 functions can have similar features.
Similar content being viewed by others
Introduction
The nm23 gene family includes two murine and six human genes1 (and references therein).2 The first, referred to as nm23-M1, was isolated on the basis of its reduced expression in highly metastatic murine melanoma cell lines, as compared with their nonmetastatic counterparts.3 Afterward, a crucial role in blocking metastasis progression has been suggested for the murine nm23-M1 and the human nm23-H1 genes that share 88% nucleotide identity and encode proteins 95% identical1,4 (and references therein). Nevertheless, in tumours such as childhood neuroblastoma, a high expression of nm23 positively correlates with tumor aggressiveness.5,6 Moreover, a serine 120 to glycine mutation in the Nm23-H1 sequence, that impairs proper protein folding,7 occurs in aggressive childhood neuroblastoma.8 Noteworthy, the mutant nm23-H1S120G cDNA transduced into human breast carcinoma cells, fails to inhibit cell motility,9 a fundamental component of the metastatic phenotype. The inhibition of cell motility is also abrogated by the transduction of the mutant nm23-H1P96S cDNA.9 This mutant reproduces the killer of prune (k-pn) mutation of the awd gene, the nm23 homologue in Drosophila melanogaster.10 The awd k−pn mutation is lethal in the genetic context of the null mutation of the prune (pn) gene involved in the eye pigment synthesis.11
The nm23 genes encode nucleoside diphosphate kinases (NDPK), exameric enzymes that catalyse the exchange of γ-phosphates between tri- and diphosphonucleosides.12 The reaction involves the transient phosphorylation of a conserved histidine, namely histidine 118 in the human enzymes.13 The NDPK activity does not correlate with the suppression of the metastatic phenotype.14
Several observations suggest an involvement of the nm23 genes in development and differentiation1 (and references therein). Specifically, their action is mainly relevant to the functional differentiation of epithelia and neural tissues.15,16,17 We have demonstrated previously that the overexpression of nm23-M1 in rat pheochromocytoma PC12 cells enhances susceptibility to nerve growth factor (NGF)-induced sympathetic neuronal cell differentiation by inhibiting proliferation and stimulating neurite outgrowth.18 Upon NGF treatment, stable nm23-M1 PC12 transfectants undergo growth arrest, express cytoskeletal proteins specific to neuritogenesis and display branching neurites within 4 days, whereas parental PC12, as well as control transfectants, require at least 8 days. Stable antisense nm23-M1 PC12 transfectants, instead, show a marked increase in the proliferative rate and are inhibited in undergoing differentiation.
Growth arrest being a prerequisite for cell differentiation, genes that negatively regulate the transition from the G1 to the S-phase of the cell cycle are involved in such a phenomenon. A crucial role is played by those belonging to the family of the retinoblastoma (RB) gene, the prototype of the oncosuppressors19,20 (and references therein). Their products, pRB, p107 and pRb2/p130, are phosphoproteins that control the function of transcription factors such as those of the E2F family mainly responsible for the S-phase entry21 (and references therein). Moreover, the RB family genes regulate embryonic development and differentiation22 (and references therein). As far as Rb2/p130 is concerned, it has been suggested that it might play a major role in maintaining the differentiated state, due to the ability of the gene product to form (with the E2F family members) stable complexes at late stages of the differentiation process.23,24,25,26,27 Nevertheless, Rb2/p130 overexpression is able to induce differentiation of neuroblastoma cells.28 High expression levels of pRb2/p130 are detectable in terminally differentiated skeletal muscle and nervous tissue.29 In PC12 cells, NGF treatment increases pRb2/p130 endogenous expression levels and Rb2/p130 overexpression is able per se to trigger the onset of differentiation.30
In this scenario, in order to elucidate the mechanisms by which the modulation of the antimetastatic nm23 gene influences PC12 cells proliferation and differentiation, we approached, in such model system, the analysis of the negative regulators of the cell cycle G1/S transition. The results herein shown provide the first evidence of interplay between nm23 and Rb2/p130 in committing PC12 cells to a more sensitive state for neuronal differentiation.
Results
Expression of the RB family proteins in stable sense and antisense nm23-M1 PC12 transfectants
PC12 cells exposed to NGF stop dividing within 7–8 days and gradually develop the phenotype of sympatethic neurons.31,32 Stable nm23-M1 PC12 transfectants, in the presence of NGF, rapidly accumulate in the G0/G1 phase of the cell cycle undergoing early morphological differentiation after 4 days of treatment. On the contrary, stable antisense nm23-M1 PC12 transfectants, upon NGF treatment, continue to proliferate without differentiating.18 In this model system we investigated the expression and postranslational modifications of the RB proteins, because of their role as negative regulators of the cell cycle G1/S transition. Protein analysis was performed on cell lysates from different control, sense and antisense stable nm23-M1 PC12 transfectants,18 both cycling and NGF-treated. Figure 1 shows Western blots chosen as representative of the experiments performed with the different clones. In cycling control and sense transfectants the bands corresponding to pRb, pRb/p130 and p107 displayed, as expected, a microheterogeneous pattern due to the presence of species with different degrees of phosphorylation. In cycling antisense transfectants the bands corresponding to the RB proteins displayed a majority of hyperphosphorylated slow-migrating forms. After 4 and 8 days of NGF-treatment, pRb and p107 showed a similar increase in the hypophosphorylated fast-migrating forms in both control and sense transfectants. The pattern of pRb2/p130 did not change between 4- and 8-day NGF-treated control transfectants, instead a dramatic increase in the protein level, in its underphosphorylated form, was detected in NGF-treated sense transfectants. The increase in pRb2/p130 expression was more evident after 4 days of NGF treatment coincident with the acquisition of the differentiated phenotype by the stable sense nm23-M1 PC12 transfectants.18 NGF-treated antisense transfectants showed a microheterogeneous pattern of all the RB proteins in agreement with their continuous proliferative activity.18
Regulation of the Rb2/p130 promoter activity by nm23-M1 in PC12 cells
The marked increase in pRb/p130 expression observed in stable nm23-M1 PC12 transfectants upon NGF treatment, prompted us to investigate whether it was due to an increase in the transcription of the Rb2/p130 gene. For this purpose, PC12 cells were cotransfected with the plasmid containing the minimal promoter region of the Rb2/p130 gene, encompassing 201 nucleotides prior to the translation codon, upstream the CAT reporter gene (hereinafter referred to as −201 CAT construct),30 together with either the empty control vector (pcDNA3), or the plasmid encoding nm23-M1 (pcDNA3-S-nm23-M1),18 or the plasmid containing the nm23-M1 coding region in the antisense orientation pcDNA3-AS-nm23-M1.18
Figure 2 shows the histogram corresponding to the CAT activity detected 2 days after the transfection with each couple of vectors in growing condition (Figure 2A) and upon NGF treatment (Figure 2B). The cotransfection of nm23-M1 increased the CAT activity by about 35 and 50% in cycling and in NGF-treated cells, respectively as compared to the basal CAT activity. On the contrary, the cotransfection of antisense nm23-M1 inhibited the basal CAT activity by about 45 and 20%, respectively. These data indicate that in PC12 cells Rb2/p130 transcription can be modulated by different nm23 levels.
Regulation of Rb2/p130 promoter activity and endogenous pRb2/p130 levels by nm23-H1 and nm23-H1 mutants in PC12 cells
In a first attempt to identify in the nm23 sequence the residues required for the induction of Rb2/p130 transcription, we also investigated the effect of different mutants of the human nm23-H1 gene on the Rb2/p130 promoter as compared with wild-type nm23-H1. PC12 cells were cotransfected with the −201 CAT construct together with either the empty control vector (pCMV) or the plasmid containing the nm23-H1 coding region (pCMV-nm23-H1)9 or one of the following plasmids containing mutant nm23-H1 cDNAs: pCMV-nm23-H1H118F (hereinafter referred to as pCMV-H118F), pCMV-nm23-M1S120G (hereinafter referred to as pCMV-S120G), pCMV-nm23-H1P96S (hereinafter referred to as pCMV-P96S).9 Histidine 118 is involved in Nm23 NDPK activity;13 serine 120 is the site of the mutation found in human neuroblastoma;8 and proline 96 corresponds to the site of the k-pn mutation of the Drosophila awd gene.11
Figure 3 shows the histograms corresponding to the CAT activity detected two days after the transfection with each couple of vectors in cycling condition (Figure 3A) or upon NGF treatment (Figure 3B). In cycling cells the cotransfection of nm23-H1 increased the CAT activity of 70% above the basal level, whereas the H118F mutant had no effect. The S120G and the P96S mutants inhibited the basal CAT activity of about 25 and 35%, respectively (Figure 3A). In NGF-treated cells the cotransfection of nm23-H1 increased the CAT activity of 25% above the control level. The H118F mutant, that was ineffective in cycling cells, increased the CAT activity of about 20%. The S120G and the P96S mutants, instead, inhibited the CAT activity of 20 and 10%, respectively (Figure 3B). We also investigated the effects of nm23-H1 and its mutants on Rb2/p130 translation in PC12 cells. Lysates from PC12 cells transiently transfected with either nm23-H1 or each of the different mutants were normalised on the basis of an equivalent expression of the endogenous and exogenous Nm23 proteins, as evaluated by Western blotting (not shown), and then analyzed for the expression of endogenous pRb2/p130. Figure 4 shows that the levels of the Rb2/p130 gene product detected in cycling and in NGF-treated PC12 transfectants 2 days after the transfection, were strongly inhibited by the S120G and P96S mutants, as also indicated by the reported relative density values.
Inhibition of PC12 cells differentiation by nm23-H1 S120G and P96S mutants
We also verified the effect on NGF-induced PC12 differentiation elicited by the expression of the nm23-H1 mutants, as compared with wild-type nm23-H1. PC12 cells were cotransfected with the plasmids containing nm23-H1 or the mutants in combination with a β-galactosidase reporter construct, as a transfection marker, and cultured in NGF containing medium. Four days after transfection, cells were stained for the β-galactosidase activity and a minimum of 200 positive cells were observed per each experiment. Cells were scored as differentiated when neuritic length exceeded at least twofold the cell body. Figure 5 shows the morphology of the PC12 cells transfected with the control pCMV vector, the pCMV-nm23-H1, the pCMV-H118F, the pCMV-S120G, and the pCMV-P96S plasmids upon 4-day NGF treatment. The histogram represents the percentage of differentiated cells observed for each type of transfection. It appears evident that nm23-H1, as its murine cognate nm23-M1,18 enhanced neuronal differentiation of PC12 cells and that the NDPK-defective H118F mutant was similarly able to promote neuritogenesis. On the contrary, the S120G and P96S mutants inhibited NGF induced differentiation.
Discussion
We have demonstrated previously that the murine antimetastatic nm23 gene is able to promote NGF-induced differentiation of PC12 cells.18 Cell cycle withdrawal is mandatory for differentiation in many cell types. Accordingly, NGF-treated PC12 cells overexpressing nm23 rapidly accumulate into the G0/G1 phase.18 The present study was aimed at establishing the link between the nm23 gene and the regulatory machinery of cell cycle during PC12 neuronal differentiation.
The genes of the retinoblastoma family, namely RB, p107 and Rb2/p130 are negative regulators of the transition between G1- and S-phases of the cell cycle and are crucial effectors in embryo development and cell differentiation. Their products are phosphoproteins that in the hypophosphorylated form modulate the function of several nuclear transcription factors mainly of the E2F family.
We investigated the expression of the members of the RB family in PC12 clones stably transduced with either sense or antisense nm23-M1 cDNA.18 Upon NGF treatment, as expected, a general increase in the dephosphorylation of the RB proteins was observed in control and sense nm23-M1 PC12 transfectants. In contrast, in the antisense nm23-M1 transfectants the three RB proteins displayed a pattern of hyperphosphorylated forms. The hyperphosphorylated forms being inactive as negative regulators of the cell cycle, this observation reflected the high proliferative activity shown by the antisense nm23-M1 PC12 transfectants despite the NGF treatment.18 Moreover, beside the increased dephosphorylation, a striking accumulation of pRb/p130 was also evident in the sense nm23-M1 PC12 transfectants.
Since NGF treatment of PC12 cells upregulates the endogenous Nm2318 and pRb2/p13030 proteins, and Rb2/p130 overexpression activates the PC12 differentiation program30, we investigated whether the modulation of the expression of nm23-M1 in PC12 cells could result into a modulation of the Rb2/p130 promoter. Our results indicated that in the PC12 model, the activity of the Rb2/p130 promoter was modulated with relation to the expression levels of nm23-M1. The stimulation of Rb2/p130 transcription, occurring upon NGF treatment of PC12 cells, was clearly enhanced by the transfection of nm23-M1 and, on the contrary, inhibited by the transfection of the antisense nm23-M1 cDNA. Moreover, the human nm23-H1 was effective in stimulating the activity of the promoter of Rb2/p130 and the synthesis of the gene product as well.
The synthesis of nucleoside triphosphates does not appear to support the role of nm23 in the suppression of the metastatic phenotype.14 We verified the effect of the NDPK defective H118F mutant on Rb2/p130 transcription and on PC12 differentiation. The mutant was still effective in increasing the Rb2/p130 promoter activity upon NGF treatment, even if at a lesser extent than wild-type nm23-H1. Accordingly, the H118F mutant was as able as wild-type nm23-H1 to up-regulate the endogenous expression of pRb2/p130 and to promote NGF-induced differentiation in PC12 cells. These results indicate that the regulation of the NGF-induced differentiation mediated by nm23 does not require the NDPK activity of the nm23 gene product, thus resembling what observed as far as cell motility inhibition,14 a parameter that well correlates with the metastatic potential of tumour cells. These data are in contrast with those described by other authors that reported a suppression of NGF- and dibutyryl cyclic AMP-induced differentiation of a PC12 sub-cell line.33 They showed a slight decrease of neurite outgrowth upon transient transfection of a NDPK defective mutant and a marked inhibition of differentiation in stably transfected clones, as compared to wild-type NDPK transfection. The discrepancy between the results might be partly due to a clonal peculiarity of the PC12 sub-cell line and to a shorter treatment period prior to evaluating the morphological differentiation. An inhibitory effect on the Rb2/p130 promoter activity was instead consequent to the expression of the S120G and P96S mutants. In agreement, the expression of PC12 endogenous pRb2/p130 was downregulated. Furthermore, a striking inhibition of NGF-induced PC12 differentiation was observed as comparing the morphology, upon NGF treatment, of S120G and P96S transfectants with control PC12 transfectants.
The serine 120 to glycine mutant NDPK retains the enzymatic activity, instead protein stability to denaturation is greatly compromised34 leading to an incorrect protein folding.7 Moreover, the mutation alters subunits interaction, resulting in the preferential formation of dimers rather than examers, relatively to the wild-type, which may affect interaction with other cellular factors.34 The proline 96 to serine mutation mimics the k-pn mutation of awd, the Drosophila nm23 homologue. The k-pn mutation alters protein assembly35 and the structure of the so-called k-pn loop that is important for NDPK subunits interaction and plays an important role in the formation and stability of the examers.35,36 Noteworthy, our data indicated serine 120 and proline 96 to be of crucial importance for Nm23-H1 to promote PC12 differentiation and to up-regulate Rb2/p130 expression. Since both mutations affect subunits interaction, it can be postulated that the regulatory function exerted by the Nm23-H1 protein in cell differentiation strictly requires the formation of high affinity examers that allow the interaction with other factors. In view of this and considering that Nm23-H1 has not been demonstrated as a transcription factor, it can be supposed that the effect on Rb2/p130 promoter activity, observed upon nm23-H1 transfection of PC12 cells, is mediated by the interaction of the Nm23 protein with regulators of Rb2/p130 transcription. It is conceivable that the expression of the S120G and P96S nm23-H1 mutant cDNAs impairs proper protein complexes assembly resulting in the inhibition of the differentiative process and of Rb2/p130 expression. Moreover, taking into account the effects on cell motility observed upon S120G or P96S cDNA transfection,9 our results suggest that nm23 antimetastatic and differentiative functions share a common pathway.
In synthesis, the present study, aimed to verify a putative interplay between nm23 and the negative regulators of the cell cycle, demonstrated the Rb2/p130 gene as a partner in driving neuronal differentiation of PC12 cells. The importance of Rb2/p130 in PC12 cells differentiation as an effector downstream the AP-2 differentiation program, has been demonstrated.30 AP-2 is a transcription factor implicated in embryogenesis37,38 and in the ectodermal differentiation program.39,40 It can be argued that nm23 enhances the susceptibility of PC12 cells to NGF-induced differentiation by promoting the onset of the differentiation program that involves AP-2 and Rb2/p130. Of note, we have herein shown that the transfection of the AS-nm23-M1 cDNA into PC12 cells, besides having an inhibitory effect on NGF-induced differentiation,18 also downregulates Rb2/p130 promoter activity. In this context, in order to better define the specific role of nm23 in driving the neuronal differentiation program, it will be of relevance to investigate whether the antimetastatic gene operates in a synergism with AP-2 in positively regulating Rb2/p130 transcription and translation.
Materials and Methods
Cell lines
PC12 cells were the original described by Greene and Tischler.32,33 Stable control, sense and antisense nm23-M1 PC12 transfectants were as described.18 Cell lines were grown in RPMI 1640 (Bio Whittaker) supplemented with 10% heat-inactivated horse serum (Hyclone Laboratories) and 5% foetal bovine serum (Hyclone Laboratories). NGF treatment was performed as previously described18 in RPMI 1640 supplemented with 1% horse serum and 100 ng/ml NGF.
Western blot analysis
Cell lysis and SDS–PAGE were performed as previously described.41 To avoid quantitative errors due to protein degradation, equal quality of cell lysates was verified by staining duplicate gels with Coomassie brilliant blue G-250 (Bio-Rad).18 After protein electroblotting to nitrocellulose,41 complete transfer was verified by staining nitrocellulose with Ponceau S (Sigma).18 Immunodetection was performed by enhanced chemiluminescence (ECL, Amersham). Primary antibodies were the followings: anti-pRb, anti-pRb2/p130, anti-p107 (all from Santa Cruz Biotechnology, Inc.), anti-GST-Nm23-M141 anti-Nm23-H1 (Transduction Laboratories).
Plasmids
Plasmids were the followings: pcDNA3 vector (Invitrogen Corp.); pcDNA3-S-nm23-M1 and pcDNA3-AS-nm23-M1 plasmids containing the full-length nm23-M1 coding region in sense and antisense orientation, respectively;18 pCMV vector (Invitrogen Corp.); pCMV-nm23-H1 containing the full-length nm23-H1 coding region;9 pCMV-nm23-H1H118F, pCMV-nm23-H1S120G, pCMV-nm23-H1P96S containing the H118F, the S120G and the P96S nm23-H1 mutant cDNAs, respectively;9 −201 CAT construct containing the minimal promoter region of the Rb2/p130 gene cloned in the pSV0t2-CAT vector;30 pCMV-β-gal plasmid expressing the β-galactosidase reporter.30
Transient transfections
PC12 cells (2×106) were transfected by electroporation at 300 V and 500 μF using a Bio-Rad Gene Pulser apparatus connected to a Bio-Rad Pulse Controller unit achieving about 30–35% transfection efficiency. When required, the electroporated PC12 cells were plated on collagen coated plates and NGF-treated as above.
CAT assays
The plasmids were individually cotransfected with the −201 CAT construct and the pCMV-β-gal plasmid into PC12 cells. After 48 h, cell extracts were normalised based on β-galactosidase activity and assayed for CAT activity as already described.42
Differentiation assays
The plasmids were individually cotransfected with the pCMV-β-gal plasmid. The transfected cells were NGF-treated for 4 days, stained for β-galactosidase activity and observed under a phase-contrast microscope.
Abbreviations
- NDPK:
-
nucleoside diphosphate kinase
- NGF:
-
nerve growth factor
- CAT:
-
chloramphenicol acetyltransferase
- β-gal:
-
β-galactosidase
- SDS–PAGE:
-
sodium dodecyl sulphate polyacrylamide gel electrophoresis
References
Lombardi D, Lacombe ML, Paggi MG . 2000 nm23: unraveling its biological function in cell differentiation J. Cell. Physiol. 182: 144–149
Tsuiki H, Nitta M, Furuya A, Hanai N, Fujiwara T, Inagaki M, Kochi M, Ushio Y, Saya H, Nakamura H . 1999 A novel human nucleoside diphosphate kinase, Nm23-H6, localizes in mitochondria and affects cytokinesis J. Cell. Biochem. 76: 254–269
Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME . 1988 Evidence for a novel gene associated with low tumor metastasic potential J. Natl. Cancer Inst. 80: 200–204
De La Rosa A, Williams R, Steeg PS . 1995 Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions BioEssays 17: 53–62
Hailat N, Keim DR, Melhem RF, Zhu XX, Eckersckorn C, Brodeur GM, Reynols CP, Seeger RC, Lottspeich F, Strahler JR, Hanash NM . 1991 High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification J. Clin. Invest. 88: 341–345
Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DJ, Steeg PS . 1993 Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas Oncogene 8: 855–865
Lascu I, Schaert S, Wang C, Sarger C, Giartosio A, Gilbert B, Lacombe ML, Konrad M . 1997 A point mutation of human nucleoside diphosphate kinase A found in neuroblastoma affects protein folding J. Biol. Chem. 272: 15599–15602
Chang CL, Zhu XX, Thoraval DH, Ungar D, Rawwas J, Hora N, Strahler JR, Hanash SM, Radany E . 1994 Nm23-H1 mutation in neuroblastoma Nature 370: 335–336
MacDonald NJ, Freije JMP, Stracke ML, Manrow RE, Steeg PS . 1996 Site-directed mutagenesis of nm23-H1. Mutation of Proline 96 or Serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells J. Biol. Chem. 271: 25107–25116
Rosengard AM, Krutzsch HC, Shearn A, Biggs J, Barker E, Margulies IMK, King CR, Liotta LA, Steeg PS . 1989 Reduced Nm23/Awd protein in tumor metastasis and aberrant Drosophila development Nature 342: 177–180
Biggs J, Tripoulas N, Hersperger E, Dearolf C, Shearn A . 1988 Analysis of the lethal interaction between the prune and Killer of prune mutations of Drosophila Genes Dev. 2: 1333–1343
Parks RE, Agarwal RP . 1973 Nucleoside diphosphokinases. In The enzymes, Boyer PD, ed New York: Academic Press 8: 307–333
Gilles AM, Presecan E, Vonica A, Lascu I . 1991 Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme J. Biol. Chem. 266: 8784–8789
MacDonald NJ, De La Rosa A, Benedict MA, Freije JMP, Krutsch H, Steeg PS . 1993 A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential J. Biol. Chem. 268: 25780–25789
Lakso M, Steeg PS, Westphal H . 1992 Embryonic expression of nm23 during mouse organogenesis Cell Growth Differ 3: 873–879
Gervasi F, Capozza F, Bruno T, Fanciulli M, Lombardi D . 1998 Identification of novel mRNA transcripts of the nm23-M1 gene that are modulated during mouse embryo development and are differently expressed in adult murine tissues DNA and Cell Biol. 17: 1047–1055
Dabernat S, Larou M, Masse K, Hokfelt T, Mayer G, Daniel JY, Landry M . 1999 Cloning of a second nm23-M1 cDNA: expression in the central nervous system of adult mouse and comparison with nm23-M2 mRNA distribution Mol. Brain Res. 63: 351–365
Gervasi F, D'Agnano I, Vossio S, Zupi G, Sacchi A, Lombardi D . 1996 nm23 influences proliferation and differentiation of PC12 cells in response to nerve growth factor Cell Growth Diff. 7: 1689–1695
Paggi MG, Baldi A, Bonetto F, Giordano A . 1996 Retinoblastoma protein family in cell cycle and cancer: a review J. Cell. Biochem. 62: 418–430
Mulligan G, Jacks T . 1998 The retinoblastoma gene family: cousins with overlapping interests Trends Genet. 14: 223–229
Nevins JR . 1998 Toward an understanding of the functional complexity of the E2F and retinoblastoma families Cell Growth Diff. 9: 585–593
Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M, Gill RM, Wong AK, Hamek PA . 1996 Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation Crit. Rev. Biochem. Mol. Biol. 31: 237–271
Raschella' G, Tanno B, Bonetto F, Amendola R, Battista T, De Luca A, Giordano A, Paggi MG . 1997 Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation J. Cell. Biochem. 67: 297–393
Shin EK, Shin A, Paulding C, Schaffhausen B, Yee AS . 1995 Multiple changes in E2F function and regulation occur upon muscle differentiation Mol. Cell. Biol. 15: 2252–2262
Corbeil HB, Whyte P, Branton PE . 1995 Characterization of transcription factor E2F complexes during muscle and neuronal differentiation Oncogene 11: 909–920
Jiang H, Lin J, Young SM, Goldstein NI, Waxman S, Davila V, Chellappan SP, Fisher PB . 1995 Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate Oncogene 11: 1179–1189
Persengiev SP, Kondova II, Kilpatrick DL . 1999 E2F4 actively promotes the initiation and maintenance of nerve growth factor-induced cell differentiation Mol. Cell. Biol. 19: 6048–6056
Raschellà G, Tanno B, Bonetto F, Negroni A, Claudio PP, Baldi A, Amendola R, Calabretta B, Giordano A, Paggi MG . 1998 The RB-related gene Rb2/p130 in neuroblastoma differentiation and in B-myb promoter down-regulation Cell Death Differ. 5: 401–407
Baldi A, Esposito V, De Luca A, Fu Y, Meoli I, Giordano GG, Caputi M, Baldi F, Giordano A . 1977 Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer Clin. Cancer. Res. 3: 1691–1697
Paggi MG, Bonetto F, Severino A, Baldi A, Battista T, Bucci F, Felsani A, Lombardi D, Giordano A . The retinoblastoma-related Rb2/p130 gene is an effector downstream of AP-2 during neural differentiation Oncogene in press
Greene LA, Tishler AS . 1976 Establishment of a noradrenergig clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor Proc. Natl. Acad. Sci. USA 73: 2424–2428
Greene LA, Tishler AS . 1982 PC12 pheochromocytoma cultures in neurobiological research. In Advances in Cellular Neurobiology, Federoff S and Hertz L, eds New York: Academic Press pp. 373–414
Ishijima Y, Shimada N, Fukuda M, Miyazaki H, Orlov NY, Orlova TG, Yamada T, Kimura N . 1999 Overexpression of nucleoside diphosphate kinases induces neurite outgrowth and their substitution to inactive forms leads to suppression of nerve growth factor- and dibutyryl cyclic AMP-induced effects in PC12D cells FEBS Lett. 445: 155–159
Chang C, Strahler JR, Thoraval DH, Qian MG, Hinderer R, Hanash SM . 1996 A nucleoside diphosphate kinase A (nm23-H1) serine 120→glicine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction Oncogene 12: 659–667
Lascu I, Chaffotte A, Limbourg-Bouchon B, Veron M . 1992 A Pro/Ser substitution in nucleoside diphosphate kinase of Drosophila melanogaster (mutation Killer of prune) affects stability but not catalytic efficiency of the enzyme J. Biol. Chem. 267: 12775–12781
Karlsson A, Mesnildrey S, Xu Y, Morera S, Janin J, Veron M . 1996 Nucleoside diphosphate kinase. Investigation of the intersubunit contacts by site-directed mutagenesis and crystallography J. Biol. Chem. 271: 19928–19934
Mitchell PJ, Timmons PM, Hebert JM, Rigby PW, Tjian R . 1991 Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis Genes Dev. 5: 105–119
Winning RS, Shea LJ, Marcus SJ, Sargent TD . 1991 Developmental regulation of transcription factor AP-2 during Xenopus laevis embryogenesis Nucleic Acids Res. 19: 3709–3714
Philipp J, Mitchell PJ, Malipiero U, Fontana A . 1994 Cell type-specific regulation of expression of transcription factor AP-2 in neuroectodermal cells Dev. Biol. 165: 602–614
Fuchs E, Byrne C . 1994 The epidermis: rising to the surface Curr. Opin. Genet. Dev. 4: 725–736
Lombardi D, Sacchi A, D'Agostino G, Tibursi G . 1995 The association of the Nm23-M1 protein and β-tubulin correlates with cell differentiation Exp. Cell Res. 217: 267–271
Martelli F, Cenciarelli C, Santarelli G, Polikar B, Caruso M . 1994 MyoD induces retinoblastoma gene expression during myogenic differentiation Oncogene 9: 3579–3900
Acknowledgements
This work was supported by Ministero della Sanità grants to D Lombardi and MG Paggi; by MURST 60% grant to D Lombardi, by AIRC to MG Paggi and by NIH grants R01CA 60999-01A1 and P01 NS 36466 and by the Sbarro Institute for Molecular Medicine to A Giordano. The Authors are grateful to Dr. PS Steeg for kindly providing the plasmids for nm23-H1 and nm23-H1 mutants, to Dr. D Mercanti for the gift of NGF and to Dr. PG Natali for helpful discussion and criticism.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by RA Knight
Rights and permissions
About this article
Cite this article
Lombardi, D., Palescandolo, E., Giordano, A. et al. Interplay between the antimetastatic nm23 and the Retinoblastoma-related Rb2/p130 genes in promoting neuronal differentiation of PC12 cells. Cell Death Differ 8, 470–476 (2001). https://doi.org/10.1038/sj.cdd.4400842
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400842
Keywords
This article is cited by
-
Characterization of a group I Nme protein of Capsaspora owczarzaki—a close unicellular relative of animals
Laboratory Investigation (2018)
-
An electroporation protocol for efficient DNA transfection in PC12 cells
Cytotechnology (2014)
-
Diva/BclB regulates differentiation by inhibiting NDPKB/Nm23H2-mediated neuronal differentiation in PC-12 cells
BMC Neuroscience (2012)
-
Sponge non-metastatic Group I Nme gene/protein - structure and function is conserved from sponges to humans
BMC Evolutionary Biology (2011)
-
Subcellular localization of Nm23/NDPK A and B isoforms: a reflection of their biological function?
Molecular and Cellular Biochemistry (2009)